Author details

Full Name

Izak Faiena

Affiliation

Columbia University Medical Center

ORCID

Career Start Year

2010

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36621997	Editorial Comment.	J Urol	2023
37210247	Survival outcomes in patients with muscle invasive bladder cancer undergoing radical vs. partial cystectomy.	Urol Oncol	2023
34638243	Overcoming Immune Resistance in Prostate Cancer: Challenges and Advances.	Cancers (Basel)	2021
31537483	Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factors.	Urol Oncol	2020
32072229	The association between N-methylnaltrexone, a peripherally acting mu-opioid receptor antagonist, and clinical outcomes in patients undergoing robotic-assisted radical cystectomy.	World J Urol	2020
32925563	A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma.	J Immunother	2020
30467596	Diagnostic biomarkers in non-muscle invasive bladder cancer.	World J Urol	2019
32071562	Intravesical Therapy for Non-muscle Invasive Bladder Cancer-Current and Future Options in the Age of Bacillus Calmette-Guerin Shortage.	Rev Urol	2019
30142318	PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.	J Urol	2019
30711333	Glutamine and the Tumor Immune Microenvironment.	Eur Urol	2019
30790015	Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma.	Cancer Immunol Immunother	2019
30719221	Multimodal treatments for advanced prostate cancer.	Oncotarget	2019
30930099	Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival.	Urol Oncol	2019
30577397	PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.	J Urol	2019
30267197	Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines.	World J Urol	2019
30509763	Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging.	Eur Urol	2019
30446452	Variation in surgical treatment patterns for patients with prostate cancer in the United States: Do patients in academic hospitals fare better?	Urol Oncol	2019
29066013	Role of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma.	Urol Oncol	2018
30252932	Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer.	Cancer	2018
30064933	Radical prostatectomy then and now: Surgical overtreatment of prostate cancer is declining from 2009 to 2016 at a tertiary referral center.	Urol Oncol	2018
30228094	Association between renal mass biopsy and upstaging to perinephric fat involvement in a contemporary cohort of patients with clinical T1a renal cell carcinoma.	Urol Oncol	2018
28479237	Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials.	J Urol	2018
29752514	Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy.	World J Urol	2018
29416316	Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma.	Drug Des Devel Ther	2018
29433974	Re: Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.	Eur Urol	2018
29433972	Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy.	Eur Urol	2018
29401003	Prostate Cancer Screening and the Goldilocks Principle: How Much Is Just Right?	J Clin Oncol	2018
29430511	Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer.	Bladder Cancer	2018
29128421	Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma.	Urol Oncol	2018
29103965	Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection.	Urol Oncol	2018
29299664	Trends in urinary diversion after radical cystectomy for urothelial carcinoma.	World J Urol	2018
28971785	Adrenalectomy for benign and malignant disease: utilization and outcomes by surgeon specialty and surgical approach from 2003-2013.	Can J Urol	2017
28253524	Intracrine androgen biosynthesis in renal cell carcinoma.	Br J Cancer	2017
29312648	Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkers.	Oncotarget	2017
26997576	Effect of Uncontrolled Diabetes on Outcomes After Cystectomy in Patients With Bladder Cancer: A Population-Based Study.	Clin Genitourin Cancer	2016
26478448	Female Urethral Reconstruction.	J Urol	2016
27843073	Off-Target Effect of Sildenafil on Postsurgical Erectile Dysfunction: Alternate Pathways and Localized Delivery System.	J Sex Med	2016
27188968	Accuracy of Multiparametric Magnetic Resonance Imaging for Extracapsular Extension of Prostate Cancer in Community Practice.	Clin Genitourin Cancer	2016
25304083	Bullying has a potential role in pediatric lower urinary tract symptoms.	J Urol	2015
26543427	Conservative Management of Urinary Incontinence in Women.	Rev Urol	2015
26380382	Tumor Enucleation of Renal Cell Carcinoma in a Solitary Kidney.	Austin J Surg	2015
26210683	Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States.	Urol Oncol	2015
26234169	Controversies in Robotics: Open Versus Robotic Radical Cystectomy.	Clin Genitourin Cancer	2015
26231860	Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study.	BMC Urol	2015
26065923	Regional Cost Variations of Robot-Assisted Radical Prostatectomy Compared With Open Radical Prostatectomy.	Clin Genitourin Cancer	2015
25891342	Large cell differentiation of metastatic prostate cancer after androgen deprivation therapy.	Can J Urol	2015
25530376	Comparative analysis of the risk of radiation exposure and cost of reduced imaging intensity for surveillance of early-stage nonseminomatous germ cell tumors.	Urology	2015
25130584	Prevention of erectile dysfunction after radiotherapy for prostate cancer.	Asian J Androl	2014
25483757	Performance of partial cystectomy in the United States from 2001 to 2010: trends and comparative outcomes.	Can J Urol	2014
25340386	Cytoreductive prostatectomy: evidence in support of a new surgical paradigm (Review).	Int J Oncol	2014

1 - 50 of 52

Giovanni Motterle

Mayo Clinic

Career Start Year 2017

Number of shared co-authors 2

Saum Ghodoussipour

Rutgers Cancer Institute of New Jersey

Career Start Year 2016

Number of shared co-authors 0

Jamil S Syed

Yale School of Medicine

Career Start Year 2015

Number of shared co-authors 4

Adam B Weiner

Northwestern University Feinberg School of Medicine

Career Start Year 2013

Number of shared co-authors 3

Giorgio Gandaglia

IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University

Career Start Year 2012

Number of shared co-authors 3

Simpa S Salami

University of Michigan Medical School ann arbor

Career Start Year 2012

Number of shared co-authors 6

Devin N Patel

university of california san diego School of Medicine

Career Start Year 2011

Number of shared co-authors 0

Ridwan Alam

Brady Urological Institute, Johns Hopkins University School of Medicine

Career Start Year 2010

Number of shared co-authors 2

Michael A Liss

University of Texas Health San Antonio

Career Start Year 2008

Number of shared co-authors 3

Adam Kinnaird

University of Alberta

Career Start Year 2007

Number of shared co-authors 7

Chang Wook Jeong

Seoul National University Hospital, Seoul National University College of Medicine

Career Start Year 2005

Number of shared co-authors 0

Jonathan L Wright

University of Washington Medical Center

Career Start Year 2005

Number of shared co-authors 3

Declan G Murphy

Peter MacCallum Cancer Centre, University of Melbourne

Career Start Year 2005

Number of shared co-authors 3

Derya Tilki

Universitatsklinikum Hamburg-Eppendorf

Career Start Year 2004

Number of shared co-authors 4

Jun Hyuk Hong

Asan Medical Center, University of Ulsan College of Medicine

Career Start Year 2002

Number of shared co-authors 0

Alberto Briganti

IRCCS San Raffaele Scientific Institute

Career Start Year 2002

Number of shared co-authors 4

Byong Chang Jeong

Samsung Medical Center, Sungkyunkwan University School of Medicine

Career Start Year 2001

Number of shared co-authors 0

Robert Jeffrey Karnes

Mayo Clinic

Career Start Year 2000

Number of shared co-authors 5

Hyun Moo Lee

Samsung Medical Center, Sungkyunkwan University School of Medicine

Career Start Year 2000

Number of shared co-authors 0

Girish S Kulkarni

Princess Margaret Cancer Centre, University Health Network, University of Toronto

Career Start Year 1999

Number of shared co-authors 1

Seong Il Seo

Samsung Medical Center, Sungkyunkwan University School of Medicine

Career Start Year 1999

Number of shared co-authors 0

Jim C Hu

Weill Cornell Medical Center

Career Start Year 1998

Number of shared co-authors 5

Niall M Corcoran

Royal Melbourne Hospital, The University of Melbourne

Career Start Year 1997

Number of shared co-authors 1

Philippe E Spiess

H. Lee Moffitt Cancer Center and Research Institute

Career Start Year 1996

Number of shared co-authors 3

Douglas S Scherr

New York-Presbyterian Hospital

Career Start Year 1994

Number of shared co-authors 2

Choung-Soo Kim

Asan Medical Center, University of Ulsan College of Medicine

Career Start Year 1993

Number of shared co-authors 0

Antonio Finelli

Princess Margaret Cancer Centre, University Health Network and University of Toronto

Career Start Year 1993

Number of shared co-authors 3

Mark Frydenberg

Monash University

Career Start Year 1988

Number of shared co-authors 3

Armen Aprikian

McGill University Health Centre, McGill University

Career Start Year 1987

Number of shared co-authors 0

Eric A Klein

Cleveland Clinic

Career Start Year 1984

Number of shared co-authors 6

row(s) 1 - 30 of 30

Amirali Salmasi

University of California San Diego

Co-authored papers 24

Karim Chamie

David Geffen School of Medicine at university of california los angeles

Co-authored papers 18

Alexandra Drakaki

David Geffen School of Medicine at university of california los angeles

Co-authored papers 16

David C Johnson

University of North Carolina School of Medicine

Co-authored papers 12

Aydin Pooli

David Geffen School of Medicine, University of California los angeles

Co-authored papers 8

Robert E Reiter

David Geffen School of Medicine at university of california los angeles

Co-authored papers 4

Neil Mendhiratta

National Cancer Institute, National Institutes of Health

Co-authored papers 3

Preeti Ahuja

David Geffen School of Medicine, University of California at Los Angeles

Co-authored papers 3

Steven S Raman

University of California, Los Angeles David Geffen School of Medicine

Co-authored papers 3

William Hsu

Co-authored papers 3

David Elashoff

David Geffen School of Medicine at University of California los angeles

Co-authored papers 3

William Hsu

American Medical Informatics Association, IEEE, Johns Hopkins University, Radiological Society of North America, University of California Los Angeles, University of California, Los Angeles

Co-authored papers 3

Anthony Sisk

University of California los angeles

Co-authored papers 2

Daniela Markovic

David Geffen School of Medicine at university of california los angeles

Co-authored papers 2

Ely R Felker

University of California, Los Angeles David Geffen School of Medicine

Co-authored papers 1

Toni K Choueiri

Dana-Farber Cancer Institute